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The ability of NSAIDs to delay bone healing has been long known, although the extent
and exact mechanism remains elusive. The present study evaluates the effect of short duration
NSAID on bone healing in dogs following experimental tibial osteotomy. Carprofen was
administered twice daily for either 0, 2, or 8 weeks following surgery. Bone healing was
evaluated radiographically using RUST scoring at 4 and 8 weeks postop. Postmortem,
quantitative CT of for bone mineral density analysis, histologic cartilage:callus ratio of the
fracture, and biomechanical testing were performed. Biomechanically, stiffness and maximum
stress were higher in dogs that received no carprofen than those that received 8 weeks.
Radiographic healing scores were the same for dogs which did not receive carprofen and those
receiving a short course, but both were more healed than dogs which received 8 weeks of
carprofen. There was no treatment effect on cartilage:callus ratio or bone mineral density.
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INTRODUCTION
BACKGROUND
Non-steroidal anti-inflammatory drugs’ (NSAIDs) ability to inhibit bone healing has been
recognized for nearly 40 years (1). Use of NSAIDs for provision of postoperative analgesia for
the vast majority of surgical procedures is ubiquitous and considered standard of care in
veterinary practice (2). Although the exact mechanism of bone healing inhibition remains
unknown, current theories postulate that COX inhibition of prostaglandin synthesis affects the
inflammatory phase of healing and leads to an uncoordinated healing response (3, 4).
In the past 25 years, administration of NSAIDs for fracture-related pain relief has come
under scrutiny in human medicine as retrospective studies (5-12) identified NSAID
administration as a risk factor for delayed union or nonunion in long bone fracture and spinal
fusion, while other studies failed to detect an effect of NSAID administration in bone healing
(13-15). Resultant literature reviews addressing NSAID use in bone healing approach the issue
by one of several methods: 1) offer no specific recommendation on NSAID usage in bone
healing (17-19), 2) acknowledge experimental NSAID-induced delays in bone healing in animal
models and urge caution in individuals with additional risk factors for delayed healing (19-21),
or 3) opine contraindication and avoidance of any and all NSAIDs when fracture healing or
spinal fusion is desired (22).
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Evidence-based recommendations on NSAID usage during fracture healing are lacking in
companion animals, and the reported effects on fracture healing in all species studied have been
variable. Decreased fracture healing in rodents and rabbits has been variably assessed using
biomechanical strength (23-30), blood flow (31), histology (24, 25, 32), bone density (23, 30,
33), histomorphometry (34-36), rate of non-unions or malunions (27, 28, 32), and radiographic
score (26, 27, 32). Two experimental studies in rats (27, 28) detected that NSAID inhibition of
fracture healing is dose-dependent, with high doses being more highly inhibitory, mirroring
clinical experience in human medicine (11). Other rodent studies which delayed administration
of NSAIDs following creation of a fracture documented a lack of negative effects of NSAIDs on
bone healing (26, 27). Interestingly, several rodent studies (27, 28, 33, 36) documented that the
initial decreases in bone healing seen are reversible once the NSAID is discontinued.
The benefit of NSAID administration in an acute trauma setting should not be
underestimated. Prostaglandins induced following induction of COX-2 in immune cells of
inflamed tissue propagate inflammation, and contribute to pain hypersensitivity. COX-2
expression is upregulated in painful states to both the peripheral site of injury as well as in
neurons of the dorsal horn of the spinal cord (37). Induction of COX-2 in neural cells of the CNS
contributes to mechanical pain, such as results from a fracture (38). Thus NSAIDs function as
multimodal analgesia with fracture-related pain by both decreasing peripheral inflammation as
well as modulating peripheral and central pain sensitization.
In veterinary medicine there is minimal research in companion animals regarding
NSAIDs’ effects on bone healing utilizing NSAIDs which are FDA approved for use in
companion animals. The majority of animal studies which have been performed in veterinary
2

species have been in rodents and rabbits being used as models for pharmacokinetic and
pharmacodynamics studies of NSAIDs which are not approved for use in companion animals.
Rather, dosages in the species tested were evaluating toxicity levels, thus doses which wouldn’t
be standard in those species. Additionally, the fracture models utilized lacked adherence to the
principles of fracture fixation as established by the Arbeitsgemeinschaft für Osteosynthesefragen
(AO) (39), thus potentially affecting the clinical significance of their findings. This is evidence
by the fact that presence of a fracture non-union (28) has been used as an outcome for
assessment of fracture healing. A single study performed in dogs (40) documented delayed bone
healing in a tibial osteotomy fracture model when long-term administration (12 weeks) of
carprofen was compared to no carprofen. However, the clinical relevance of long-term
administration of an NSAID in management of patients with fractures is questionable.
BIOLOGY OF BONE HEALING
Bone healing can be described as occurring via one of two processes: primary bone
healing and secondary bone healing. The type of healing which occurs is dependent on the type
of fracture reduction, the implants’ effect on the fracture, amount of strain present across the
fracture, and biological environment. In order for primary bone healing to occur, absolute
stability must be present where the amount of strain at the fracture site has functionally been
eliminated. Thus accomplishing this type of fixation is not possible in the absence of a
completely reconstructable fracture.
The goal of fracture healing and fixation can take one of two approaches to either 1)
eliminate interfragmentary strain, with goal of creation of absolute stability to provide an
environment for primary bone healing, or 2) maintain a low strain environment through bridging
3

techniques and implants which provides relative stability for secondary bone healing to occur. In
order to create an environment for bone healing via secondary bone healing (i.e. endochondral
ossification), the osteotomy fracture model used in this study was given a 2mm gap.
Secondary bone healing is a complex biological process, and one of the most remarkable
feats of healing within the body, as it heals without forming a fibrous scar, instead completely
regenerating the tissue (41). It is the method by which bone healing occurs in nature without
stabilization, and involves an organized response from both the periosteum of the bone and the
soft tissue capsule surrounding the fracture. It does not require anatomic reduction or rigidly
stable conditions; rather, secondary bone healing is enhanced by micromotion and weightbearing (41, 42). Fractures allowed to heal via secondary bone healing are typically stabilized via
interlocking nail, lengthening or bridging plate, external fixation, or with a plate/rod fixation of a
complicated, comminuted fracture (42).
Following an initial trauma, the vasculature of the tissues surrounding the bone are
disrupted, resulting in hemorrhage. The onset of hemorrhage causes platelet activation and
degranulation (44) leading to a release of growth factors and cytokines to the hematoma milieu
(42), and ambient hypoxyia induces production of chemotactic factors implicated in cell
migration, differentiation, and new bone formation (43). This disruption leads to decreased
oxygen tension in the area, as well as reduced nutrients in the local environment. Reduction in
oxygen tension acts as a regulatory stimulus for many cells including mesenchymal stem cells
(MSCs) and bone progenitor cells (45, 46). Hypoxia-inducible factors (HIFs) are key regulators
of the cellular adaptive response to microenvironmental hypoxia, such as seen in a fracture,
following disruption of the blood supply, and regulates the expression of multiple genes affecting
4

cell survival, angiogenesis, and cell metabolism (47). In a hypoxic environment, HIF-α1, which
is normally suppressed, accumulates in the nucleus and along with other activation units,
regulates expression of downstream target genes including VEGF, SDF-1 and CXCR4 (48-51).
The initial pro-inflammatory response consisting of macrophage infiltration to the site of
the injury, has been shown to be vital for endochondral ossification (52). Following macrophage
recruitment, T-lymphocytes migrate to the fracture hematoma and initiate the adaptive immune
response (53). At the same time, large amounts of pro-inflammatory cytokines are released,
namely tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1), IL-6, IL-11, and IL-18 (54-56).
These molecules thus create a chemotactic gradient to recruit inflammatory cells and promote
angiogenesis (57). The concentration of TNF-α is said to peak within 24-hours post-trauma, and
return to baseline within 72 hours (58), during which time it is expressed by macrophages and
other inflammatory cells. TNF-α is further believed to mediate an effect by induction of a
secondary inflammatory signal and as a chemotactic molecule to recruit necessary cells (59). Of
the pro-inflammatory molecules produced, IL-1 and IL-6 are thought to be the most important
for fracture healing. The expression of IL-1 and TNF-α overlap in a biphasic mode where
macrophages produce IL-1 initially which then induces production of IL-6 by osteoblasts, as well
as promoting production of primary cartilaginous callus. IL-1 also promotes angiogenesis at the
injured site by activating either of its 2 receptors (57, 59, 60). IL-6, on the other hand, is only
present in the acute phase of healing as it stimulates angiogenesis, production of vascular
endothelial growth factor (VEGF), and differentiation of osteoblast and osteoclasts from bone
progenitor cells (61).
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In order for any organ, including bone, to regenerate, MSCs must be recruited,
proliferate, and differentiate into their respective progenitor cell; in the case of bone, osteogenic
cells. The activation and recruitment of MSCs is multifactorial and incompletely understood. It is
has been demonstrated, however, that both local MSCs derived from the damaged tissue, as well
as circulating MSCs collaborate in fracture repair and healing (62). Additionally, the biological
mechanism is highly regulated by signaling molecules, including growth factors, proinflammatory molecules, and angiogenic factors (63).
Platelet-derived growth factors (PDFGs) released from the site of a fracture hematoma
have been shown to promote endogenous MSC migration to the fracture site from remote areas
of the body in humans (64). Additionally, cytokines produced by macrophages and natural killer
(NK) cells can stimulate MSC recruitment (65, 66). Chemokine expression, such as stromal cellderived factor 1 (SDF-1), are upregulated at the site of injury following a fracture (67). SDF-1 is
considered the master regulator for C-X-C chemokine receptor 4 (CXCR4)-positive MSCs, and
both contribute to migration of CXCR4 positive MSCs to a fracture site (62, 68), as well as
regulating repair activity (68). Evidence of a role for circulating osteogenic progenitor cells’
participation in fracture healing has also been demonstrated in a murine model (69). Importantly,
it is the initially hypoxic microenvironment (due to disruption of the vascularity surrounding a
fracture) which directly contributes to production of chemokines, and recruitment of bone
progenitor cells to the site of fracture, which then causes HIF-1α-induced SDF-1 expression that
stimulates the migration and homing of circulating CXCR4-positive MSCs (48).
Following the initial formation of a hematoma, a fibrin-rich granulation tissue forms over
the fractured end over the course of 7-9 days (41). Although it provides little stability to the
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fracture, it is able to withstand higher levels of tension and thus withstand the mobility of the soft
tissues inherent following a fracture (42). Simultaneously, intramembranous ossification is
occurring subperiosteally, both adjacent to the fracture ends and subperiosteally.
Concurrently with inflammation and continuing during formation of a soft callus and
chondrogenesis, intramembranous ossification occurs at between the periosteum and underlying
cortex (42). Intramembranous ossification is distinct from endochondral ossification in that
MSCs differentiate directly into osteoblasts and begin forming bone without the cartilaginous
intermediate. The intramembranous process of bone healing is confined to the fracture between
the periosteum and cortex, thus is not sufficient to stabilize the fracture alone. It is visible on
radiographs relatively early within the healing process.
With the appearance of a robust bed of granulation tissue, inflammation ends and soft
callus formation (chondrogenesis) commences. This granulation tissue consists of endothelial
cells, fibroblasts and leukocytes. A provisional extracellular matrix is composed of fibrin, and
acts as a temporary scaffold. The matrix, initially, is avascular, and is deposited by fibroblasts
and MSC attracted to the area by chemotactic agents within the matrix a cascade of molecular
signaling resulting in collagen types I and II. Members of the transforming growth factor beta
(TGF-β) superfamily have shown to be of great importance in this process (41). Once MSC are
recruited, the matrix continues to remodel and undergo conversion to chondrocytes, i.e.
chondrogenesis. Other materials present in the cartilaginous callus include aggrecan, type II
cartilage, and other cartilage-specific proteins (42).
For bone regeneration to occur, the soft cartilaginous callus must be transformed into
bony callus and later bone. The process of turning cartilage into bone reprises the embryologic
7

process of endochondral ossification, during which cells proliferate and differentiate, the cell
volume increases, and increases in both cell volume and matrix deposition occur (70). The
strength of similarity between the embryologic process of endochondral ossification and bone
development and generation have been strengthened by identification of a family of molecules,
the Wnt-family (71). The Wnt-family is believed to regulate MSCs differentiation into
osteoblastic lineage. Additionally, these molecules are thought to regulate bone formation via
osteoblasts. Fracture site chondrocytes continue to proliferate and as they do, become
hypertrophic and begin to secrete extracellular matrix which calcifies. This process is
orchestrated by macrophage colony stimulating factor (M-CSF), receptor activator of nuclear
factor kappa B ligand (RANKL), osteoprotegerin (72). TNF-α initiates resorption of the
mineralized cartilage, and M-CSF and RANKL. Additionally, genes for collage type II are
downregulated and collagen type X are upregulated (72). Collagen type X is specific to
endochondral ossification and can be used as a marker for such. In order to make way for matrix
calcification, matrix metalloproteinases (MMP) are upregulated to remove the cartilaginous
matrix. Vascular ingrowth is also occurring during this phase and requirement of vascular
endothelial growth factor (VEGF) during endochondral ossification is well documented (73-75).
Induction of VEGF by the hypoxia-inducible factor (HIF) pathway in areas of low oxygen
tension has also been documented in the avascular areas of a cartilaginous callus (76). HIF
directly increases VEGF transcription as it is a transcription factor VEGF gene expression.
Although assuredly hypoxia is one impetus for VEGF production, VEGF has been found to be
matrix bound, thus its release via matrix metalloproteinases (MMPs) may be an additional
pathway in healing fractures (77).
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As the chondrocytes continue to hypertrophy, they eventually undergo apoptosis. Once
the mineralization of the cartilage has enough structural strength to attenuate strain to survivable
levels for osteoclasts and osteoblasts (42), the advancing osteoclasts remove the mineralized
fibrocartilage and deposit osteoid for formation of woven bone. The woven bone, having
replaced all hard callus, will completely bridge the callus, and provides and maintains enough
rigid structure to resume activity. Radiographically, the bone appears to have a larger diameter
and shape may alter from the original appearance of the bone. Over a period of several months to
years, the woven bone is converted to lamellar bone with primary and secondary osteons.
EVALUATION OF FRACTURE HEALING
A method to consistently and accurately monitor fracture healing is not currently
available in the standard clinical setting. Being able to evaluate the rate and stage of healing is
important as this evaluation directs clinical management and ability to bear full weight or return
to normal activity in the veterinary patient. It is also helpful in being able to identify fractures
that have stalled in their healing sequence and are in a state of delayed or non-union. Equally,
evaluation of fracture healing in a research setting should be able to be performed quantitatively
in order to facilitate useful studies and effectively evaluate different treatment methods.
The central functional attributes of bones are, 1) their ability to regulate calcium
hydroxyapatite mineral deposition and resorption, and 2) the ability to form the microstructure
needed to meet the biomechanical load applied by the forces to that bone within the animal (87).
Methodologies for evaluation of these two components include imaging, biomechanical testing,
serological markers, and observation of clinical improvement.
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The existence of a range of modalities to evaluate fracture healing is indicative of the
failure of any one modality alone to provide sufficient information on fracture healing. Although
evaluation of fracture union radiographically is not without fault, it remains the current gold
standard for evaluating fracture union in veterinary medicine. The relatively low cost, ubiquity of
availability, and familiarity of clinicians with the imaging modality has led to its continued use,
in the face of other options.
Considering the widespread use of radiographs to assess bone healing, only limited
attempts have been made to establish definitions of radiographic fracture union. Furthermore, use
of radiographs for identification of the stage of bone healing has largely been inconclusive (7981). Research into standardization of radiographic union has been sparse, but within the last 10
years development of two scoring systems by human traumatologists for fractures of the femoral
neck via use of the Radiographic Union Score for Hip (RUSH) and tibial fractures, Radiographic
Union Score for Tibia (RUST) has come to light (82, 83). The RUST was originally developed
for assessment of cortical healing in fractures stabilized with an interlocking nail. In such a
situation, because the implant is placed within the medullary canal, two cortices can be
visualized on orthogonal views of the affected bone, thus scoring of 4 cortices is achievable in
the majority of radiographs. Each cortex is scored for presence or absence of callus, and whether
the fracture line is visible or invisible. A score of 1 is awarded when the fracture callus is absent,
and fracture line is visible. A 2 is awarded when the callus is present, but fracture line is visible.
A 3 is awarded when the callus is present and the fracture line is invisible. Thus, a completely
unhealed bone would score a 4/12 and completely healed bone a 12/12. (Figure 1)
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Figure 1

RUST scoring rubric

RUST score system for radiographic evaluation of fracture healing.

This scoring system requires observation of 4 cortices; this was possible in the tibial
fractures stabilized with interlocking nails for which this scoring system was created. When other
methods of stabilization are utilized, it is possible that the implant will obscure cortices making a
similar scoring system more difficult. In Perlepe et al 2018 (84), it was reported that radiologists’
ability to assess cortical healing in plated fractures was significantly reduced (31-56%) compared
to those which were stabilized with interlocking nails (90-97%). As such, additional methods for
fracture healing evaluation may be desirable in instances of a type of internal fixation besides
interlocking nails, particularly in a research setting.
Computed tomography has been shown to have excellent accuracy in determining the
bone mineral density of cortical bone. Although dual-energy x-ray absorptiometry (DEXA) was
long the standard of care for measurement of bone mineral density and thus osteoporosis in
humans, the bone mineral density which can be calculated and extrapolated from quantitative
computed tomography (QCT) has been shown to be even more useful than DEXA both in terms
of accuracy, as well as prediction of fracture risks. In steroid-induced osteoporosis in
11

postmenopausal women, bone mineral density of the lumbar spine as measured by QCT, but not
by DEXA, was found to be an independent predictor of all types of vertebral fractures (85).
Although QCT shows promise for prediction of fractures in patient populations at risk for
spontaneous fracture, i.e. in those with decreased bone mineral density to resorption of mineral,
use of QCT for fracture healing has not been evaluated to show the same promise. One study
(86) evaluated fracture healing assessment methods via 4 different methodologies. Twelve weeks
following an experimental tibial osteotomy in dogs, QCT, magnetic resonance imaging, singlephoton absorptiometry, and DEXA were performed to evaluate fracture healing as compared to
radiographic union. The authors noted that QCT had the best correlation with bone healing of the
four modalities; however agreement was still poor. It possible that QCT, although valuable for
evaluation of bone mineral density, is poor at evaluating radiographic union due to the inherent
heterogeneity and disorganization of bone structure within the period which it would be
compared to radiographic union.
In a research setting, biomechanical properties of bone are commonly assessed.
Frequently used assessments of these include bending and torsion of bones, as bones experience
both of these forces in vivo. Tension and compression tests are infrequently used due to the
variation within the alignment of fractures, and asymmetry of a fracture callus. Outcomes
obtained, regardless of type of test include strength, stiffness, rigidity, and toughness of healing
bone. Additionally, non-destructive loads can be used to evaluate the callus and can quantify
bending stiffness in multiple planes (87).
Histological examination of bone is another means of evaluating bone healing. Although
multiple stains can be used to differentiate tissue phenotype, it is of greatly utility to stain tissue
12

in such a way to improve and enhance visualization of that tissue by distinguish via distinct
coloration from an adjacent and contiguous tissue section. For differentiation of cartilage and
bone, Safrinin-O fast green has been widely used, and has been shown to be effective for
measuring cartilage thickness in joints with osteoarthritis (88). Regardless of staining protocol,
ideally the histological tissue discrimination should be enhanced via the stain chosen.
PATHOPHYSIOLOGY OF PAIN IN FRACTURES
Pain is described as “an unpleasant sensory and emotional experience associated with
actual or potential tissue damage, or describe in terms of such damage”, by the International
Association for the Study of Pain (89). Nociception, on the other hand, is the “neural process of
encoding noxious stimuli” (89). It is thus the physiologic process which underlies conscious
perception of pain. Unlike with pain, nociception does not require consciousness to occur, and
continues even in the presence of general anesthesia if techniques are not employed to block or
regulate the transduction, transmission, and modulation (90). Because pain requires conscious
awareness, perception is a key aspect of its presence.
At a physiological level, pain begins with presence of a noxious stimulus to sensory
neurons. Pain has been associated with bony pathology, including fractures, bone marrow edema
syndromes in humans, osteomyelitis, osteoarthritis, and bone cancer (91). Fracture pain, as
described by afflicted humans, is a sharp and well-localized pain. It was originally believed that
bone pain was not perceived unless the periosteum was involved (92). However, pain is also
noted in patients who have bone pathology limited to the bone marrow with no evident periosteal
pathology (93). Based on these clinical and experimental observations, it would appear both the
periosteum and medullary canal of bones are innervated by primary afferent sensory neurons,
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capable of transducing and transmitting nociceptive information (91). Bone pathology has also
been noted to produce allodynia and hyperalgesia. These syndromes are consistent with central
sensitization of cutaneous afferent neurons and their central projections (94).
With the advent of immunohistochemical markers for neuropeptides, nerve fibers which
innervate cortical bone, bone marrow, and periosteum, have been identified as both sensory and
autonomic (92, 95-100). The periosteum is innervated by 2 types of neurons: large diameter, fast
conducting neurons with encapsulated endings which provide information about non-painful
stimulus, and small diameter, slow conducting free fiber endings which are typical of nociceptors
(91). The smaller, slow conducting nerve fiber which supply the periosteum are most likely to
generate pain associated with mechanical stimulation of the periosteum of bone, i.e. pain
associated with fractures. These nerve fibers’ conduction velocities and responses to mechanical
stimuli suggest roles in both fast, sharp bone pain and slow burning bone pain.
The peripheral afferent sensory neurons have central terminals synapsing with secondorder neurons in the dorsal horn of the spinal cord (101). These second-order neurons are either
interneurons or projection neurons which then cross to the contralateral side of the spinal cord
and carry the signal up the spinal cord, also known as the process of transduction (102). Central
sensitization occurs as a result of continued activation or nociception in the periphery, leading to
prolonged hyperexcitability of the pain circuits of the central nervous system (CNS) (103).
Although the complete mechanisms of central sensitization are multifaceted and complex, COX2 expression increases significantly locally following initiation of inflammation (104), as well as
centrally within the neurons, glia, spinal cord endothelial cells, and brain (104, 105). The release
of PGE2 in the dorsal root ganglion, due to the COX-2 activation peripherally, is essential to the
14

development of inflammatory hyperalgesia in peripheral tissue (106). The increase in PGE2
within the CNS following peripheral inflammation is due to the plasticity of the CNS which
permits increased spontaneous neuronal activity, reduced activation thresholds, and expansion of
the “receptive field”, i.e. increased sensitivity to nociception in an area outside the trigger zone,
specifically increasing mechanical pain sensitivity (107, 108). These together are manifested as
the previously mentioned hyperalgesia (increased sensitivity to noxious stimuli) and allodynia
(the interpretation of non-noxious stimulus as pain) seen with fractures.
Because NSAIDs target the source of pain from fractures in the periphery by targeting
receptors expressed at the nociceptor peripheral terminals, as well as blocking the sensitizing
effect of prostaglandins within the dorsal horn of the spinal cord, NSAIDs as a class of drug can
be said to affect central analgesic action in addition to their peripheral action (109). As
multimodal analgesia is tenet of modern analgesia, there is a strong argument for administration
of NSAIDs in both the pre- and post-operative fracture stabilization period as they can
significantly ameliorate the pain associated with the fracture and thus reduce morbidity in the
patient.
THEORY OF USE AND PHARMACOKINETICS AND DYNAMICS OF NSAIDS
In the event of injury to a cell, damage to the cell membrane causes release of
phospholipids, the most common constituent of the cell membrane. Due to the enzymatic effect
of phospholipase A2 (PLA2), the previously amphipathic molecules are broken down to
arachidonic acid. These molecules are largely recycled back to reform the phospholipid bilayer
which make up the eukaryotic cell wall. In the presence of certain stimuli, however, arachidonic
acid may be acted upon by cyclo-oxygenase or lipo-oxygenase enzymes to form eicosanoids (i.e.
15

20-carbon structures) which have various roles in homeostasis and disease. Of those eicosanoids,
there are several specific forms which are then transformed and become prostaglandins,
prostacyclins, and thromboxane. All of these products act locally and have various
immunological and inflammatory roles as well as having important physiological functions.
Prostanoid receptors are G-protein coupled receptors which span the cell membrane (110) and
classification of 5 subdivisions exist according to the COX metabolite, EP for PGE2, which when
activated leads to further signaling pathways.
Cyclo-oxygenase (COX) enzymes exist in 2 isoforms: COX-1 and COX-2. COX-2 is
generally considered an inducible isoform which is present in small amounts in most tissues but
which is significantly upregulated in the event of stimulation, such as by pro-inflammatory
cytokines, growth factors, and lipopolysaccharide (LPS) found in the outer cell wall of gram
negative bacteria, as well as mitogens. COX-2 consists of approximately 600 amino acids, is 70
kDa in weight, and has 60% homology with COX-1 for binding amino acids and NSAIDs (110).
Although COX-1 and COX-2 compete for arachidonic acid substrate, COX-2 will preferentially
act as the dominant enzyme.
NSAIDs inhibit the biosynthesis of prostaglandins by preventing the substrate
arachidonic acid from binding to the COX enzyme active site. NSAIDs usage is ubiquitous in
companion animal veterinary medicine, and indeed, amongst all veterinary species. Due to these
drugs being uncontrolled or schedule, they are commonly prescribed and dispensed by
veterinarians to treat a variety of types of pain. They have both anti-inflammatory and analgesic
properties, making them useful, in spite of their profile of side effects and contraindications.
Most NSAIDs are now recognized to cause inhibition of both COX-1 and COX-2 enzymes,
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depending on NSAID class, but also dependent on species variation. The selectivity of an
NSAID for COX-2 vs. COX-1 can be expressed as the COX-1:COX-2 inhibitory ratio, with
those with a higher preference for COX-2 being a higher number (111). The published
comparisons between non-selective and COX-2 selective NSAIDs varies among drugs used,
animal species and study technique used (112, 113). In a 2004 study by Lees et al (110), study
results highlighted the differences amongst species and concluded that carprofen, in humans, is
relatively COX-1 selective, whereas in dogs and cats carprofen showed preferential activity
against COX-2.
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THE EFFECT OF SHORT AND LONG-TERM NSAID ADMINISTRATION ON
OSTEOTOMY HEALING IN DOGS
OBJECTIVES
The objective of this study is to identify if short-term administration of carprofen, an
FDA approved COX-2 specific NSAID, to dogs with appropriate fracture fixation, given at an
appropriate dosage, negatively affects healing 8 weeks postoperatively. Based on clinical
impression and personal observation that the majority of patients that receive NSAIDs following
a fracture or osteotomy receive only a short duration of NSAIDs (2 weeks or less), we
hypothesized there would be no difference between dogs administered carprofen for 14 days
postoperatively and those that did not receive carprofen. We further hypothesized that both
groups would be different to dogs receiving carprofen for the 8 week duration of the study in
biomechanical strength, histopathological analysis of cartilage remaining in the callus,
radiographic healing, and bone mineral density.
MATERIALS AND METHODS
ANIMALS
Eighteen purpose-bred, sexually intact adult hound dogs from commercial breeding
facilities were used in this study. The size and age of the dogs were controlled to limit variation
between groups. The study was performed over 1.5 years with 6 dogs (2 per treatment group)
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evaluated at three separate time points. The endpoint of each study corresponded with a terminal
educational lab for 4th year veterinary students. The 6 dogs in each group were randomly
assigned to one of 3 treatment groups using a list randomizer (https://www.random.org/lists/): no
carprofen (0-weeks), carprofen at 2.2 mg/kg orally every 12 hours for 14 days (2-weeks), and
carprofen at 2.2 mg/kg orally every 12 hours for the 8 week duration of the study (8-weeks). All
dogs had preoperative complete blood count, blood serum chemistry, and heartworm antigen
testing performed prior to inclusion in our study. Animal care and use was in accordance with
the NIH guidelines for the care and use of laboratory animals and all protocols were approved
and strictly overseen by the Institutional Animal Care and Use Committee.
TIBIAL OSTEOTOMY
Food was withheld for the 12 hours prior to surgery. Dogs were pre-medicated with
0.005-0.01 mg/kg of acepromazine and 0.1 mg/kg of hydromorphone intramuscularly [IM], then
induced with propofol 2-6 mg/kg intravenously [IV] to effect for endotracheal intubation.
Following intubation, femoral and sciatic nerve blocks were performed with bupivacaine 0.5%
(1mg/kg) using a Stimpod nerve locating device (Xavant Technology) and 21g 4” Ultrastim2104
needle. Anesthesia was maintained with isoflurane inhalant in oxygen for the duration of the
procedure. Radiographs of the left tibia were obtained under anesthesia, prior to surgery.
Cefazolin 22 mg/kg IV was administered 30 minutes prior to incision and every 90 minutes of
surgery. Cefazolin was discontinued following completion of surgery.
All osteotomies were performed on the left tibiae. A medial approach was made to the
tibia, and the center of the tibia was located by measuring the distance between needles within
the stifle and tibotarsal joint. A jig was placed on the medial tibia to maintain alignment
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following the osteotomy. An oscillating saw (Aesculap, Center Valley, PA) was used to perform
a transverse osteotomy under saline irrigation mid-tibia. Following osteotomy, the saw blade was
positioned in the osteotomy to maintain a 2mm gap while a pre-contoured 3.5 mm 8-hole, broad
DCP plate (Veterinary Orthopedic Implants, St. Augustine, FL) was applied to the medial aspect
of the tibia with eight 3.5 mm self-tapping cortical screws placed in standard AO/ASIF fashion.
The saw blade and jig were then removed, site was flushed, and the wound closed routinely in 2
layers with an intradermal skin closure. Postoperative radiographs of the left tibia were obtained,
dogs were fitted with Elizabethan collars, an adhesive bandage applied (Suresite with Telfa pad),
after which dogs were allowed to recover from anesthesia.
POSTOPERATIVE CARE AND MONITORING
Hydromorphone 0.05mg/kg was administered subcutaneously every 4 hours for the first
24-36 hours postop. The morning following surgery, dogs in the 2-week and 8-week carprofen
groups began receiving oral carprofen, and all dogs were administered Simplicef (cefpodoxime)
5-10 mg/kg orally every 24 hours for 2 weeks. Oral tramadol (4-6 mg/kg) was administered to all
dogs every 12 hours following discontinuation of subcutaneous hydromorphone and was
continued for 2 weeks following surgery. Cerenia (maropitant citrate) was administered to dogs
showing symptoms of nausea at 1 mg/kg subcutaneously every 24 hours as needed for the first
24 to 48 hours postoperatively. A superficial bandage covering of the incision was maintained
for the first 48-72 hours. The dogs were housed in separate runs with 3’5” mesh netting ceilings
to minimize jumping and administered their prescribed treatment based on group assignment. Ecollars were maintained until their incisions were deemed healed by a veterinarian (HG). During
incision healing, dogs were monitored for development of infection defined as either the
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presence of swelling of the leg, drainage from the incision, or decreased weight bearing on the
operated limb. Antibiotics were initiated empirically based on these clinical signs. At 4 weeks
postop, dogs were sedated with butorphanol 0.2 mg/kg IV and dexmeditomidine 5 mcg/kg IV,
orthogonal left tibial radiographs were obtained, and dexmeditomidine reversed with equal
volume atipamezole IM.
EUTHANASIA AND CT ANALYSIS
At the end of the 8 week study period, the dogs were part of an educational lab, at the
conclusion of which they were humanely euthanized while under general anesthesia with
pentobarbital IV to effect. Following euthanasia, 8 week postoperative radiographs were
performed of the left tibia. The tibial implants were then removed, and computed tomography
(CT) of both hind limbs was performed with a phantom (QRM Forearm CT phantom: QRM,
Möhrendorf, Germany) for later analysis of bone mineral density. (Figure 1)
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Figure 2

Post-mortem axial CT of tibiae with phantom for BMD calculations.

Axial CT images show both right and left tibiae/fibulae with phantom with known BMD. HUw =
water-equivalent Hounsfield units; HUB = bone-equivalent Hounsfield units.

BIOMECHANICAL ANALYSIS
The hind limbs were harvested, and the right and left tibiae disarticulated at the stifle,
tarsus, and fibula, and were stripped of surrounding muscle and fascia. The specimens were then
wrapped in gauze moistened with 0.9% sodium chloride solution, placed in plastic Ziploc bags,
and transported on ice to the biomechanical testing facility. Mechanical testing was performed
within 2 hours after harvest of specimens. Mechanical testing included non-destructive 3-point
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bending tests on all normal and osteotomized tibias. All samples were tested using a universal
testing machine (MTI-2K, Measurements Technology, Inc., Marietta, GA) with a 2000 lb. load
cell. Experiments were displacement-controlled at a rate of 6 mm/min. Load versus displacement
curves were created and the linear region of the curve was identified to determine the stiffness
(N/mm) and proportional force limit (N). Stiffness was defined as the slope of the best fit line
through the linear region of the curve. The proportional force limit was defined as the maximum
force on the linear region of the curve. Proportional force limit (rather than yield or max load)
was obtained due to the inherent differences in the failure portion of the curve between normal
and osteotomized tibias.
Geometric measurements of the bones were obtained from CT scans taken 8 weeks post
operatively following euthanasia of the animals with diameter of the cortex and medullary canal
on a sagittal section performed in quadruplicate. The area moment of inertia (AMI, Equation 1)
was calculated using CT measurements. In addition to the measurements obtained from load cell
testing (stiffness and proportional force limit), the following material properties (i.e., those
dependent on geometry) were calculated: maximum stress (Equation 2), elastic modulus
(Equation 3), and flexural rigidity (Equation 4) (1).

4

A𝑀𝐼 =

(𝜋∗[{𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟 𝑜𝑓 𝑒𝑥𝑡𝑒𝑟𝑛𝑎𝑙 𝑐𝑜𝑟𝑡𝑒𝑥} − {𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟 𝑜𝑓 𝑡ℎ𝑒 𝑚𝑒𝑑𝑢𝑙𝑙𝑎𝑟𝑦 𝑐𝑎𝑛𝑎𝑙}4 ])
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(1)

𝑀𝑎𝑥𝑖𝑚𝑢𝑚 𝑠𝑡𝑟𝑒𝑠𝑠 =
(0.125×𝑚𝑎𝑥𝑖𝑚𝑢𝑚 𝑙𝑜𝑎𝑑 𝑡𝑜 𝑓𝑎𝑖𝑙𝑢𝑟𝑒×𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 𝑏𝑒𝑡𝑤𝑒𝑒𝑛 𝑠𝑢𝑝𝑝𝑜𝑟𝑡𝑖𝑛𝑔 𝑝𝑜𝑖𝑛𝑡𝑠 𝑜𝑛 𝑡ℎ𝑒 𝑠ℎ𝑎𝑓𝑡×𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟 𝑜𝑓 𝑐𝑜𝑟𝑡𝑒𝑥)
𝐴𝑀𝐼

(2)
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𝐸𝑙𝑎𝑠𝑡𝑖𝑐 𝑚𝑜𝑑𝑢𝑙𝑢𝑠 =

𝑠𝑡𝑖𝑓𝑓𝑛𝑒𝑠𝑠×(𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 𝑏𝑒𝑡𝑤𝑒𝑒𝑛 𝑠𝑢𝑝𝑝𝑜𝑟𝑡𝑖𝑛𝑔 𝑝𝑜𝑖𝑛𝑡𝑠 𝑜𝑓 𝑡ℎ𝑒 𝑠ℎ𝑎𝑓𝑡)3
48×𝐴𝑀𝐼

𝐹𝑙𝑒𝑥𝑢𝑟𝑎𝑙 𝑟𝑖𝑔𝑖𝑑𝑖𝑡𝑦 = 𝐸𝑙𝑎𝑠𝑡𝑖𝑐 𝑚𝑜𝑑𝑢𝑙𝑢𝑠 × 𝐴𝑀𝐼

(3)

(4)

All values were normalized to those of the contralateral control (intact) tibia to calculate a
recovery rate (2). The recovery rate = (osteotomy leg/normal leg)*100.
HISTOLOGY
Bones were placed in 10% buffered formalin solution following biomechanical testing.
Once fixed, they were decalcified in Kristensen’s solution (formic acid/sodium formate) for
approximately 1 month at 25 - 30 degrees Celsius. Samples were then embedded in paraffin and
sectioned at 4 microns, then stained with hematoxylin and eosin (H&E) and safranin O-fast
green, to highlight remaining cartilage within the bone callus. Each slide was then scanned using
a slide scanner (Aperio CS2, Aperio, Ventura, CA). An area 5 mm proximal and 5 mm distal to
the original osteotomy was analyzed on sections stained with safranin O-fast green using image
analysis software (Aperio ImageScope, Leica Biosystems, Nussloch GmbH, Germany). A
cartilage-to-callus ratio was then calculated using a positive pixel count algorithm to calculate
strong positive pixels (red and orange, consistent with cartilage) over total pixel area (red and
orange plus blue area, representing tissues within the callus, excluding white background).
Callus was defined as the tissue at the level of the fracture including fibrous tissue, woven bone,
blood vessels and associated nerves. (Figure 2)
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Figure 3

Histologic sections of tibial osteotomy 8 weeks postoperatively.

Slides demonstrate cartilage remaining in callus vs. no callus remaining. Top row: 8-week group. Bottom row: 2-week group. (A)
H&E stain of osteotomy section. (B) Safranin-O green (cartilage stains red) (C) Algorithm results for calculation of cartilage : callus
ratio. Positive pixel count (red and orange) : total pixel count (dark blue + red and orange).
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RADIOGRAPHIC ANALYSIS
Radiographs from 4 and 8 weeks postoperatively were evaluated using the Radiographic
Union Scale in Tibial fractures (RUST) scoring system (3). Originally developed and validated
for tibial fractures repaired interlocking nails in humans, RUST assesses fracture healing at the 4
cortices on orthogonal radiographic views. Each bone is scored on a 4-12 point scale, summing
the score for the 4 cortices. One point is awarded for visible fracture line with no callus, 2 points
for visible fracture line with callus, and 3 points for bridging callus with no visible fracture line.
Each of the three scorers, a radiologist (EB), surgeon (RB), and surgery resident (HG), were
blinded to treatment and study time-point. All scorers were given a written description of the
RUST prior to scoring.
QUANTITATIVE CT (QCT) IMAGE ANALYSIS
The post-mortem CT scans of the tibiae were analyzed to obtain the phantom rod pixel
values to estimate the water-equivalent Hounsfield units (𝐻𝑈𝑊 ) and bone-equivalent Hounsfield
units (𝐻𝑈𝐵 ). An average pixel value of HU was obtained for cortical bone of normal and
osteotomized bone, as well as the callus, at the level of the osteotomy by using three 2mm
elliptical regions of interest (ROI). The bone mineral density (BMD) was then estimated using
the following formula (Equation 5) as previously described (4).

𝐵𝑀𝐷𝑋 = 𝐻𝐴𝐵 ×

𝐻𝑈𝑋 −𝐻𝑈𝑊
𝐻𝑈𝐵 −𝐻𝑈𝑊

Where the phantom rod bone density equivalent, 𝐻𝐴𝐵 = 200 𝑚𝑔⁄𝑐𝑚3 and the
measured pixel value from CT is 𝐻𝑈𝑋 .
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(5)

STATISTICAL METHODS
The effect of NSAIDs on measures of biomechanical strength, bone mineral density,
histology, and radiographic union score were assessed by generalized linear mixed models using
PROC MIXED, SAS for Windows 9.4 (SAS Institute, Inc., Cary, NC). For the measures of
biomechanical strength (stiffness, proportional force limit, maximum stress, elastic modulus, and
flexural rigidity), the normal tibia, osteotomized tibia values, and recovery rate values were
dependent variables in separate models. For bone mineral density, the density of the callus,
normal and osteotomized tibia values, and recovery rate values were each analyzed in separate
models. A manual forward selection process was followed for variable selection. The model was
first fit with only treatment as a fixed effect. The model was then run with either sex, weight,
age, or infection as candidate fixed effects in addition to treatment. If one of these additional
fixed effects were significant, it was added to the model and the process repeated with each of
the remaining candidate fixed effects. Treatment remained in all models regardless of its p-value.
Differences in least squares means with Tukey-Kramer adjustment for multiple comparisons
were determined for outcomes with a significant fixed effect. For the radiographic union score
models, the average of the three observers’ scores for each radiograph was used as the dependent
variable. For these models, both treatment and time (4 weeks or 8 weeks) were included as fixed
effects. Dogs’ identity within trial and trial were included as random effects. The variable
selection process described above was followed for the radiographic union score model. The
distributions of the conditional residuals for all models were evaluated to ensure the assumptions
of normality and homoscedasticity had been met for the statistical models. An alpha level of 0.05
was used to determine statistical significance.
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Statistical analysis for agreement between the three observers’ assessments of radiographic
union score was assessed by intra-class correlation (ICC) using PROC MIXED, SAS for
Windows 9.4. The ICC is a measure of rating reliability, ranging from 0 to 1, which compares
the variability of different scorings of the same radiograph to the total variation across all
observers. To assess the agreement among the three observers, an intercept-only model was fit
with radiographic union score as the outcome and observer identity and radiograph identity as
random effects. The restricted maximum likelihood estimation method was utilized. Covariance
parameters from the models were then utilized to calculate the intra-class correlation (ICC) using
PROC SQL (5, 6).
RESULTS
DEMOGRAPHICS
A total of 17 of the 18 sexually intact hound dogs completed the study. Eight males and 9
females were enrolled. The mean body weight was 27.65 kg (±4.43). Ages ranged from 8
months at the time of euthanasia to 15 months. The second cohort of dogs were six 6 month old
at the start of the study, thus dividing the young dogs evenly amongst study groups. All study
groups had 6 dogs with the exception of the 8-week NSAID group, which had 5. One dog was
humanely euthanized 8 days post-operatively due to complications associated with a suspected
underlying bleeding disorder. A high rate of superficial infection was noted: out of 17 dogs, 10
(58.8%) developed superficial surgical site infections, defined for the purpose of statistical
analysis, as dogs which were treatment beyond the perioperative period with antibiotics was
initiated on at least one occasion
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BIOMECHANICAL TESTING
No biomechanical differences were detected between dogs receiving no carprofen and
those receiving 2 weeks of carprofen, or between dogs receiving 2 weeks of carprofen and 8
weeks of carprofen in either osteotomized or normal bones (p>0.05). (Table 1)
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Table 1

Biomechanical measures and calculations from data obtained 8 weeks post-surgery

Structural Properties
0-Weeks

SD

2-Weeks

SD

8-Weeks

SD

Normal Bone (¶, **)

1498.1

284.3

1498.1

275.1

1632.0

250.9

Osteotomy Bone (‡)

751.5

301.4

634.5

226.7

534.5

134.8

Recovery Rate (‡,§)
Stiffness (N/mm)

52.4

25.8

43.1

15.5

33.2

9.0

Normal Bone

499.7

98.3

471.0

114.1

545.8

134.8

Osteotomy Bone

290.2

70.5

243.5

80.1

222.0

74.6

Recovery Rate (§)

59.6*

16.1

52.7

13.6

42.5*

15.2

Proportional Force Limit (N)

Intrinsic Material Properties
Maximum Stress (MPa)
Normal Bone

124.9†

9.4

130.9

22.7

141.1†

24.3

Osteotomy Bone

31.8*

12.1

21.2

6.8

17.2*

10.2

Recovery Rate (‡)

25.4*

9.3

16.4

5.2

12.4*

8.0

Normal Bone (†,††, §)

7023.3

1617.5

6978.4

1783.6 7865.7

1628.5

Osteotomy Bone

1735.9

584.2

1179.7

626.9

886.9

667.2

24.8

7.2

16.3

6.9

11.9

10.4

21.3

4.6

20.1

4.9

23.3

5.8

Elastic Modulus (MPa)

Recovery Rate
6

Flexural Rigidity (10 N/mm)
Normal Bone

Osteotomy Bone
12.4
3.3
10.4
3.4
9.5
3.2
Recovery Rate (§)
59.6*
17.7
52.7
13.6
42.5*
15.2
Arithmetic means and standard deviation (SD)). Significance is based on differences in least
square means from generalized linear mixed models (p-value <0.05), thus numbers below.
(*) Groups differing based on treatment. 0-week > 8-week; no difference was found between 0and 2-weeks, or 2-weeks and 8-weeks. \
†) Significant only for animals at lower weights (22.5kg, 25kg; not 27.5kg or 30.0kg)
(‡) Infection decreased values.
(§)Younger age increased values/older age had lower values.
(¶) Younger age decreased values
(**) Lower for lighter animals
(††) Females > males
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The osteotomized tibias in dogs that received no carprofen recovered more stiffness than
those that received carprofen for 8 weeks (p=0.0351) when adjusted for age. Younger dogs’
osteotomized tibias recovered more stiffness (p=0.0009).
Normal tibias of young animals had a lower proportional force limit than those of older
dogs (p=0.0123). Lighter dogs’ normal tibias had a lower proportional force limit of than those
of heavier dogs (p=0.0315). Regardless of whether dogs received carprofen or not, in
osteotomized tibias, infection decreased the proportional force limit (p=0.024) and decreased the
proportional force limit recovery rate (p=0.0112). The osteotomized tibias of older dogs also had
a decreased recovery rate of proportional force limit (p=0.0305).
The osteotomized tibias of dogs receiving carprofen for 8 weeks were less able to
withstand stress (p=0.0419), and had decreased recovery rates of maximum stress (p=0.0140),
compared to those which did not receive carprofen (p=0.0172), when adjusted for the occurrence
of infection (p=0.0055).
Weight and treatment interacted in normal tibias: normal tibias of dogs that received 8
weeks of carprofen had higher maximum stress those which received no carprofen (p=0.0197
when assessed for 22.5kg dogs; p=0.0256 when assessed for 25kg dogs); this did not hold true
when assessed for dogs with higher body weights of 27.5, 30.0, or 32.5 (p≥0.1231). The normal
tibias of dogs receiving 8 weeks of carprofen had a lower recovery rate of flexural rigidity than
those not receiving carprofen (p=0.0351), when adjusted for age (p=0.0009). Older dogs had
lower recover rates of flexural rigidity in osteotomized tibias. No other treatment effect was
noted.
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The normal tibias of female dogs had higher elastic moduli than males (p=0.0014).
Elastic modulus decreased with increasing age of dogs in normal tibias (p=0.0092).
BONE MINERAL DENSITY (BMD)
Treatment did not affect BMD of normal bone (p=0.7466), osteotomized tibia
(p=0.2432), extracortical callus (p=0.0835), or recovery rate of the osteotomized tibia: normal
tibia (p=0.5331). Normalized bone mineral density at the osteotomy was not affected by
treatment in any of the models. In the normal tibia, BMD was higher in heavier dogs (p=0.0132).
Bone mineral density was higher in tibias of older dogs (p=0.0343). (Table 2)
Table 2

Bone mineral density based on calculations from quantitative computed
tomography.

Bone Mineral Densities (BMD)
0-Weeks

SD

2-Weeks

SD

Normal*

1372.9

56.7

1335.8

40.6

Osteotomy †

1000.7

126.3

897.6

87.3

0.7

0.1

0.7

0.1

768.0

85.6

Recovery Rate
Callus

719.8 146.8

8-Weeks
1357.8

SD
51.2

950.1 147.5
0.7

0.1

617.8 108.1

(*) = weight is significant. Heavier animals have denser bone.
(†) = age is significant. Older dogs have higher mineral density at the osteotomy.
HISTOLOGY
There was no treatment effect on the cartilage to callus ratio within a 1 cm area around
the callus (p=0.2534). (Table 3)
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Table 3

Cartilage to callus ratio mean and standard deviation.

Histologic Means of (Cartilage : Callus ratio)*100
0-Weeks

SD

2-Weeks

SD

8-Weeks

SD

2.81
3.32
3.02
2.37
5.17
2.14
[(cartilage: callus)*100]. Significance amongst groups is based on differences in least square
means from generalized linear mixed models (p-value <0.05). No difference was noted between
groups.
RUST (RADIOGRAPHIC UNION SCORE OF THE TIBIA)
The interobserver agreement (ICC) between the 3 scorers was 0.76, which falls in the
range of “good” level of agreement.44,45 No difference in radiographic score was detected
between dogs which received no carprofen and those that received 2 weeks of carprofen at either
4 weeks (p=0.9923) or 8 weeks (p=0.9923) postoperatively. (Figure 3) The RUST of both dogs
which received no carprofen and those that received 2 weeks of carprofen was greater (i.e. more
healed) than that of dogs which received 8 weeks of carprofen at both 4 weeks postoperatively
(p=0.0011) and 8-weeks postoperatively (p=0.0011). (Table 4)
Table 4

Mean of RUST and standard deviation.

Mean of RUST by Group and Time Point
4 Weeks

0-Weeks

SD

2-Weeks

SD

8-Weeks

SD

8.67*

1.61

7.33*

1.24

6.40 †

1.06

10.72*
1.32
10.67*
1.19
8.60 †
0.91
8 Weeks
Means and standard deviations of RUST data. In effect, the extent of healing in the 0-week and
2-week groups was greater than that of the 8-week group.
* = No difference between groups. (4 week, p=0.068; 8 weeks, p=0.9860)
† = Less healed compared to * groups.
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DISCUSSION
Evaluation of RUST scores for determination of radiographic healing would lead us to
accept our hypothesis that there is no difference in fracture healing between dogs given no
NSAIDs and a 2-week course of NSAIDs, and that both were more healed than dogs receiving 8
weeks of carprofen. However, only some of the biomechanical testing results (stiffness recovery
rate, maximum stress, and maximum stress recovery rate) were consistent with the radiographic
findings, with no difference detected of other biomechanical measures between treatment groups.
Moreover, the histological appearance and bone mineral density of the callus showed no
difference between any of the treatment groups, all of which would cause use to reject our
secondary hypothesis. Due to these seemingly differing results, we must examine the stages of
bone healing where NSAIDs may be most influential, and whether our test parameters are
sensitive enough to adequately assess bone healing 8 weeks postoperatively in the dog.
The exact point at which bone healing is affected by NSAIDs has not been fully
elucidated. In our study, the first time point at which objective evaluation was performed was 4
weeks postoperatively. Given that no difference in radiographic healing scores was detected
between dogs who did not receive carprofen and those who received 2 weeks of carprofen, but
both were more healed than dogs who received 8 weeks of carprofen at 4 weeks postoperatively,
it may reasonably be presumed that a difference of 2 weeks of administration of NSAIDs is
sufficient both to delay healing as well as to reverse a delay in healing. In one previous study (7),
prostaglandin E2 (PGE2) levels within the fracture callus were elevated in rats during the first 2
weeks following a fracture, then tapered after 14 days. Early elevation in PGE indicates a role in
bone healing. The same study (7) detected with administration of either a non-specific or COX-2
specific NSAID for 7 days, PGE2 levels rebounded higher than in control rats 14 days after
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initial fracture, thus further validating a role of PGE2 during the early phases of bone healing.
The role of COX-2 was examined by Zhang et al (8) using genetic knock-out mice lacking COX1 and COX-2 gene expression: decreased fracture healing 21 days post fracture was detected in
the COX-2 knockout mice, while wild-type mice were similar to those lacking COX-1.
Furthermore, cell-culture-raised bone marrow stromal cells lacking COX-2 had a 50% decrease
in the number and area of bone nodules compared to either COX-1 deficient or wild-type cells.
Finally, the addition of PGE-2 or bone morphogenetic protein-2 to COX-2 deficient bone
marrow stromal cell culture returned bone area and numbers of nodules to the same as wild type,
all of which are consistent with bone metalloproteinases being downstream to PGE-2 and PGE-2
(and therefore COX-2) being necessary for bone formation.
In our dogs, the 2 mm fracture gap was designed to model endochondral ossification. In
endochondral ossification, mesenchymal cells first differentiate into chondrocytes, which
subsequently undergo terminal differentiation and apoptosis, leading to calcification of the
matrix (9). Endochondral bone formation is dependent upon osteoblast differentiation from
osteoprogenitor cells (MSCs). In a tibial fracture model of mice lacking COX-2 genes (8),
reduced osteoblastogenesis in diaphyseal fractures was noted. This finding was supportive of a
critical requirement of COX-2 for mesenchymal stem cell differentiation which is, in turn, a
crucial step in endochondral ossification. Lack of mesenchymal stem cell proliferation due to
COX-2 selective NSAID administration may be partially responsible for decreased endochondral
ossification noted in other studies (2), and a lower RUST score at 4 weeks and 8 weeks
postoperatively in dogs that received 8 weeks of carprofen in our study. Histologically, our
model failed to document this difference using a more objective cartilage: callus ratio than one
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previously described (2). Biomechanically, however, our data are consistent with incomplete
bony union causing decreased maximum stress in osteotomized tibias of dogs that received 8
weeks of carprofen. A lack of MSC proliferation may partially explain the difference in
biomechanical properties of bone noted in dogs receiving long-term NSAIDs.
Consistent with the previous study in dogs (2), long-term administration of carprofen
negatively affected radiographic fracture healing of the tibia in our study using the RUST scoring
system. The RUST was created by physicians (3) to improve the reliability of traumatologists’
fracture healing assessment and has shown substantial ICC of 0.86 (95% CI 0.79-0.91) and high
intraobserver reliability (ICC, 0.88; 95% CI, 0.80-0.96). A recently published report (10) in
human medical literature aimed to determine radiologists’ ability to assess healing of surgically
treated long bone fractures on radiographs found that fracture edges were only seen in only 71%
to 81% of the 560 cortical segments evaluated. Furthermore, radiographic union scores could
only be calculated in 58% to 75% of fractures. Scoring was significantly less frequently
calculable in plated (31-56%) than in fractures stabilized with interlocking nails (90-97%). In our
study, the RUST system was used by 3 observers examining radiographs of 17 dogs’ tibias at 2
different time points postoperatively. In spite of RUST originally being designed for evaluation
of human tibial fractures repaired with interlocking nails, the agreement between observers in
plated dog tibias was also high (ICC 0.76). In all radiographs of osteotomized tibias that we
evaluated, only 4 out of 34 radiographs had one cortex which was not visible, (i.e. 4 cortices out
of 136 examined, or 2.9% of all cortices evaluated). For those cortices, a score was estimated
based on callus appearance caudal to the plate. In spite of the RUST scoring system being used
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differently than originally intended and not validated for use in dogs, it allowed for a quantitative
and repeatable assessment of radiographic union in this study.
The variability in the effect of short-term administration of carprofen on biomechanical
properties detected in our study is consistent with previous reports (7, 11). Gerstenfeld et al (7)
showed in rats that NSAIDs had no effect on torsional strength (torque to failure), but that shear
modulus was decreased by long-term NSAIDs. Though 3-point bending rather than torque to
failure was evaluated in our study, long-term NSAIDs affected only some biomechanical
assessments of bone strength in our study as well. It is possible that either the variation within
groups was too large, the differences between groups were too small to observe, or there were
too few dogs per group to reach significance (type II error). For those measure for which no
significance was detected between groups, the difference between least squares means for
treatment and a 95% confidence interval was calculated (Table 5).
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Table 5

Differences and 95% confidence intervals for the least squares means

Differences and 95% confidence intervals for the least squares means

Stiffness Normal
Tibia
Stiffness
Osteotomized Tibia
Proportional Force
Limit Normal Tibia

Pvalue
0.509
7
0.212
6
0.372
5

0-Weeks vs 2Weeks
28.7 (-71.2 to
128.5)
46.7 (-36.7 to
130.1)

0-Weeks vs. 8Weeks
29.0 (-134.4 to
76.4)
74.1 (-13.8 to
162.0)

2-Weeks vs. 8Weeks
-57.7 (-163.0 to
47.7)
27.5 (-60.4 to
115.4)

-0.03 (-213.22 to
213.17)

-133.1 (-359.0
to 92.8)

-133.1 (-359.0 to
92.8)

74.2 (-175.74 to
324.18)

193.17 (-67.4 to
453.7)

118.95 (-141.1 to
379.0)

Proportional Force
Limit Osteotomized
Tibia
Maximum Stress of
Normal Tibia

0.300
8
0.369
6

-6.0417 (-25.7 to
13.6)

-13.8870 (-34.6
to 6.8)

-7.8452 (-25.5 to
12.8)

Elastic Modulus of
Normal Tibia

0.616
9

44.8939 (-1387.2
to 1476.9)

-582.87 (2092.4 to 926.6)

-627.76 (-2137.2
to 881.7)

Elastic Modulus of
Osteotomized Tibia

0.109
9

556.26 (-228.75
849.02 (25.7 to
292.76 (-530.6 to
to 1341.3)
1672.3)
1116.1)
1223624 (-1237107 (-2460731 (Flexural Rigidity of 0.509
7
3037531 to
733958 to
6957582 to
Normal Tibia
5484780)
3259744)
2036120)
1991981 (3163578 (Flexural Rigidity of 0.212
1171597 (-259386
6
1566966 to
587405 to
Osteotomized Tibia
to 4922580)
5550928)
6914561)
Differences and 95% confidence intervals for the least squares means of the treatment groups
where a significant difference between treatment groups was not detected for biomechanical
measures.
No change in conclusions were reached following these calculations. In human medicine,
inability to perform antemortem biomechanical testing as well as limitations of radiography as a
sole gauge of fracture healing has led to development of more objective methods of fracture
evaluation. One such example is an implantable strain sensor which is placed across a healing
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fracture (12). This device was created to be used adjunctively with radiographic union
assessment for evaluation of fracture healing.
Using the RUST, no difference was detected between healing of osteotomized tibias in
dogs receiving no carprofen and those that received 2 weeks of carprofen at either 4 or 8 weeks
postoperatively. Due to the complexity and thus heterogeneity of a fracture callus, we posited
bone healing analysis could be improved using QCT to examine the bone mineral density and
thus quantify endochondral ossification at the fracture callus. However, no treatment effect was
observed on bone mineral density of the fracture callus. This may imply the stage of bone
healing captured 8 weeks postoperatively is not affected by delays in bone healing due to
carprofen. In humans, however, QCT is used more commonly as an estimate of bone mineral
density for identification of bones at risk for fracture (i.e. osteoporosis) than for bone healing
(13). A study (14) evaluating fracture healing 12 weeks post-osteotomy in dogs with QCT,
magnetic resonance imaging, single-photon absorptiometry, and dual-energy x-ray
absorptiometry, noted that QCT had the best correlation with bone healing of the four modalities;
however agreement was still poor (R2=0.6). Thus, QCT for bone mineral density appears a poor
measure of bone healing when compared with radiographic union.
No effect of carprofen administration was detected with the cartilage to callus ratio in our
fracture model 8 weeks postoperatively. This conflicts with other studies where greater cartilage
content was noted in mice following a COX-2 specific inhibitor (7), and in dogs with long-term
administration of carprofen 12 weeks postoperatively (2). However, length of time between
fracture and evaluation 27 and longer-term administration of carprofen (2) may explain difference
in outcome. Furthermore, because the previous definition of fracture callus was more subjective
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(2), interpretation of the cartilage : callus ratio and direct comparison with this study should be
avoided.
Limitations of this study include population variation due to sex, age, weight, and
superficial infection rate. Within our statistical model, these variants were accounted for so as to
minimize the effect on differences detected due to treatment within our 3 groups. (Table 1)
Further limitations include the small sample size and the simplified fracture model as it relates to
clinical relevance.
Based our findings, a short course of NSAIDs administered in the perioperative period
appear to be safe for fracture healing, but should be stopped following a 1-2 week course until
the fracture or osteotomy is healed radiographically. This is of particular relevance for patients
who receive NSAIDs chronically for management of arthritis undergo fracture repair or
osteotomy procedures, such as TPLO or TTA. Cessation of NSAIDs following the immediate
postoperative period should be strongly considered in light of the findings of this study.
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CONCLUSION
Short-term administration of carprofen to dogs following fracture repair results in no
delay in radiographic healing; however, long-term administration decreased biomechanical
strength and radiographic healing of the tibial osteotomy. Histological evaluation of cartilage
within the fracture callus and bone mineral density of the fracture callus were inadequate
assessments of bone healing 8-weeks post-osteotomy in our model. Given the desirable effects of
NSAIDs following trauma and minimal measurable adverse effects at 8 weeks post-operatively,
short-term administration of carprofen in dogs appears safe for fractures that lack other risk
factors for delayed healing. Longer duration of administration of NSAIDs following fracture
repair should be avoided to prevent delays in bone healing.
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